A platform for anatomic pathology

A precise, modern platform for anatomic pathology laboratories.

AltaPath partners with independently operated pathology laboratories, giving them shared infrastructure and steady, long-term backing — scientific, calm, deliberate.

EST. 2026
Focus
Anatomic pathology
Footprint
Multi-state
Model
Network of partner laboratories
Platform

One platform.
Many laboratories.

AltaPath brings together a thoughtfully organized group of healthcare teams. Each part of the network has its own focus — clinical operations, management services, and real estate work in their own lanes, sharing infrastructure while protecting the integrity of each laboratory practice.

AltaPath provides capital, shared services, and steady backing to a network of laboratories that keep operating under their own clinical leadership. We’re not a reference lab and we’re not a clinical brand — we’re the platform that lets independent laboratories keep doing what they do well, with more room to grow and modern infrastructure to grow into.

Each part of the network handles the work that varies by state and specialty: laboratory operations, management services, and the real estate that anchors each site. AltaPath takes on the work that doesn’t vary — finance, compliance, technology, and long-term planning.

A note on how we’re organized. AltaPath supports a family of partner entities, each set up for a specific operational, clinical, or regulatory purpose. We’re glad to walk through how it all fits together with serious partners and counterparties.
Histology laboratory bench with microscope slides and microtome
Approach

How we think about the work.

Three principles shape every laboratory we partner with. They’re deliberately conservative — the point is to be the steady hand in a moment of change.

01

Operational continuity

Laboratory teams keep their leadership, their staff, and their relationships. The platform takes on the work that pulls them away from the bench — billing, contracts, IT, compliance — and returns the time.

02

Scientific infrastructure

Modern laboratory information systems, digital pathology, and quality programs are deployed once and shared. Scale lets us invest in instruments and software that no single small laboratory could justify.

03

Long-term capital

We capitalize each entity for the work it actually does — clinical, services, or real estate — and hold for the long arc of value creation, not the next quarter. Owners and operators participate in the upside they help build.

Partner with us

Two ways to start a conversation.

We work with two kinds of partners: laboratory owners considering the next chapter of their practice, and capital partners looking for disciplined exposure to healthcare services. Either path begins the same way — a quiet, confidential introduction.

For laboratory owners

You built the practice. We help you decide what comes next.

For owners weighing succession, partnership, or full integration. Conversations are confidential and there is no obligation to proceed.

  • Continue operating under your laboratory’s name and clinical leadership.
  • Offload billing, payer contracts, IT, and compliance overhead.
  • Real estate and operations capitalized in separate, purpose-built entities.
  • Equity rollover available for owners who want continued participation.
For capital partners

Disciplined exposure to a fragmented, defensible market.

For institutional investors and family offices interested in healthcare services with built-in real-asset support. Materials are shared on a confidential basis with qualified counterparties.

  • Multi-state platform with room to grow.
  • Operating, services, and real-estate components organized for clarity and resilience.
  • Long-hold orientation; no public market for interests.
  • Diligence package available on request.
Leadership

The people behind the platform.

AltaPath is led by a small team with combined backgrounds in healthcare operations, clinical management, regulatory compliance, and institutional capital. Detailed biographies are shared on request.

Chief Executive Officer · Chief Investment Officer
Dr. Matthew Sherwood
Chief Operations Officer
Mr. Andrew DeVito